{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T01:04:58Z","timestamp":1722906298137},"reference-count":13,"publisher":"Informa UK Limited","issue":"3","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["The European Journal of Contraception & Reproductive Health Care"],"published-print":{"date-parts":[[2017,5,4]]},"DOI":"10.1080\/13625187.2017.1328170","type":"journal-article","created":{"date-parts":[[2017,5,25]],"date-time":"2017-05-25T06:20:01Z","timestamp":1495693201000},"page":"170-171","update-policy":"http:\/\/dx.doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Treatment of hyperandrogenism in women with ethinylestradiol and cyproteroneacetate"],"prefix":"10.1080","volume":"22","author":[{"given":"Alfred O.","family":"Mueck","sequence":"first","affiliation":[{"name":"Research Centre of Women\u2019s Health and Women\u2019s Hospital, University of Tuebingen, Tuebingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of the global AWARE (Appropriate care for Women with AndRogen Excess) group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2017,5,25]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d6423"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)91929-5"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)91928-7"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)91927-9"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.159.1.65"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/14.6.1500"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1016\/S0010-7824(01)00307-9"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2921"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2890"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d2139"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d2151"},{"key":"CIT0012","unstructured":"French National Agency for Medicines and Health Products Safety \u2013 ANSM. Rationale for the triggering of procedure under Article 107i of Directive 2001\/83\/EC on cyproterone\/ethinylestradiol (2\u2009mg\/0.035\u2009mg) presented by ANSM, France [Internet]. Available from: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Referrals_document\/cyproterone_ethinylestradiol_107i\/Procedure_started\/WC500139271.pdf"},{"key":"CIT0013","unstructured":"European Medicines Agency. Benefits of Diane 35 and its generics outweigh risks in certain patient groups \u2013 PRAC recommendation endorsed by CMDh. EMA\/31830\/2013."}],"container-title":["The European Journal of Contraception & Reproductive Health Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13625187.2017.1328170","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T11:24:30Z","timestamp":1693308270000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13625187.2017.1328170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,4]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,5,4]]}},"alternative-id":["10.1080\/13625187.2017.1328170"],"URL":"https:\/\/doi.org\/10.1080\/13625187.2017.1328170","relation":{},"ISSN":["1362-5187","1473-0782"],"issn-type":[{"type":"print","value":"1362-5187"},{"type":"electronic","value":"1473-0782"}],"subject":[],"published":{"date-parts":[[2017,5,4]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iejc20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iejc20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2017-05-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}